ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting …
roche
-
-
ZURICH (Reuters) – Roche has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss drugmaker said on Thursday. The new test …
-
By Julie Steenhuysen CHICAGO (Reuters) – Swiss drugmaker Roche is closing down most clinical trials of its experimental Alzheimer’s drug gantenerumab after it failed to slow advance of the mind-robbing …
-
ZURICH (Reuters) – Roche Holding has named Matt Sause, head of Roche Diagnostics’ North America region, to lead the group’s diagnostics business, the Swiss drugmaker said on Monday. The move …
-
By Natalie Grover LONDON (Reuters) – The results of a key Alzheimer’s drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of …
-
ZURICH – Roche has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said …
-
ZURICH – Roche board member Paul Bulcke, the current chairman of Nestle, will stand down from the Swiss drug-maker’s board of directors after its annual general meeting next year, the …
-
By Brenna Hughes Neghaiwi ZURICH – Roche’s newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of coronavirus, …
-
ZURICH – Roche’s $20.7 billion move to buy back nearly a third of its voting stock from fellow Swiss drugmaker Novartis will give it more strategic flexibility, Chairman Christoph Franz …